Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1995-4-20
pubmed:abstractText
Combinations of penicillins with beta-lactamase inhibitors have become acceptable treatments for mixed bacterial infections. The objective of this multicenter, randomized, open-label study was to compare the efficacy, safety, and tolerance of ticarcillin/clavulanate with clindamycin/gentamicin (with or without ampicillin) when administered to adult and pediatric patients with intra-abdominal infections. A total of 993 patients 2 years of age or older were entered in this trial if they had suspected or bacteriologically documented intra-abdominal infection. Of these, 341 were determined at the time of operation to have intra-abdominal infection. Cure rates at the time of final assessment were 79%, 80%, and 82% for ticarcillin/clavulanate, and clindamycin/gentamicin without or with ampicillin, respectively (P = 0.829, Cochran-Mantel-Haenszel). The most frequent reason for failure was development of an intra-abdominal abscess (6% of patients overall), followed by wound infections (4%), and persistent fever (3%). Two patients who had received ticarcillin/clavulanate and five who had received clindamycin/gentamicin required discontinuation of the study regimen because of adverse drug reactions. The bacteria isolated most frequently from study failures were E. coli, B. fragilis, Pseudomonas, and Streptococci. In this study, ticarcillin/clavulanate was as effective as the combination of clindamycin/gentamicin for the treatment of intra-abdominal infections.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0003-1348
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
297-303
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7893090-Adolescent, pubmed-meshheading:7893090-Adult, pubmed-meshheading:7893090-Aged, pubmed-meshheading:7893090-Aged, 80 and over, pubmed-meshheading:7893090-Bacterial Infections, pubmed-meshheading:7893090-Child, pubmed-meshheading:7893090-Child, Preschool, pubmed-meshheading:7893090-Clavulanic Acid, pubmed-meshheading:7893090-Clavulanic Acids, pubmed-meshheading:7893090-Clindamycin, pubmed-meshheading:7893090-Digestive System Diseases, pubmed-meshheading:7893090-Drug Therapy, Combination, pubmed-meshheading:7893090-Female, pubmed-meshheading:7893090-Gentamicins, pubmed-meshheading:7893090-Humans, pubmed-meshheading:7893090-Male, pubmed-meshheading:7893090-Middle Aged, pubmed-meshheading:7893090-Ticarcillin, pubmed-meshheading:7893090-Treatment Failure, pubmed-meshheading:7893090-Treatment Outcome, pubmed-meshheading:7893090-beta-Lactamases
pubmed:year
1995
pubmed:articleTitle
Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
pubmed:affiliation
Department of Surgery, Texas Tech, El Paso 79905.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study